Literature DB >> 10411680

Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus.

K Yan1, A Kudo, H Hirano, T Watanabe, T Tasaka, S Kataoka, N Nakajima, Y Nishibori, T Shibata, T Kohsaka, E Higashihara, H Tanaka, H Watanabe, T Nagasawa, S Awa.   

Abstract

BACKGROUND: The detailed mechanisms of glucocorticoid action in idiopathic nephrotic syndrome and progressive glomerulonephritides have not been clearly elucidated. The pharmacological actions of glucocorticoids are mediated by their binding to an intracellular protein, the glucocorticoid receptor (GR). The determination of GR localization in normal glomerular cells is essential to elucidate the mechanisms of glucocorticoid action in various glomerular diseases.
METHODS: We carried out an immunoblot examination using antihuman GR-specific antibody and homogenates of isolated normal human glomeruli and mesangial cells in culture. Immunohistochemical examinations were also performed on normal human kidney specimens at light and electron microscopic levels. The nuclear translocation of GRs elicited by ligand binding was further investigated by confocal laser-scanning microscopic inspection of freshly isolated glomeruli and mesangial cells cultured with dexamethasone.
RESULTS: An immunoblot examination demonstrated the presence of a 94 kDa protein, a molecular weight consistent with that of GRs, in the homogenates of glomeruli and cultured mesangial cells. By light microscopic examination, GRs were strongly detected in the nucleus and moderately in the cytoplasm of all glomerular cells, parietal and visceral epithelial cells, endothelial cells, and mesangial cells. By electron microscopic examination, the nuclear GRs of all glomerular cells were found to be diffusely distributed in the euchromatin. Additionally, the immunofluorescence intensities of nuclear GRs in isolated glomeruli and mesangial cells in culture became more intense by the addition of dexamethasone.
CONCLUSIONS: Our findings suggest that all subsets of human glomerular cells definitely express the GR protein, which potentially undergoes translocation by glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411680     DOI: 10.1046/j.1523-1755.1999.00503.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  The Rho-GTPase binding protein IQGAP2 is required for the glomerular filtration barrier.

Authors:  Yuya Sugano; Maja T Lindenmeyer; Ines Auberger; Urs Ziegler; Stephan Segerer; Clemens D Cohen; Stephan C F Neuhauss; Johannes Loffing
Journal:  Kidney Int       Date:  2015-07-08       Impact factor: 10.612

Review 2.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

Review 3.  Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

Review 4.  Podocytes from the diagnostic and therapeutic point of view.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pflugers Arch       Date:  2017-05-16       Impact factor: 3.657

5.  Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; R S Thalgahagoda; Pathum V Dissanayake; Shamali Abeyagunawardena; Y A Illangasekera; Umeshi I Karunadasa; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2017-03-24       Impact factor: 3.714

6.  Investigations of Glucocorticoid Action in GN.

Authors:  Christoph Kuppe; Claudia van Roeyen; Katja Leuchtle; Nazanin Kabgani; Michael Vogt; Marc Van Zandvoort; Bart Smeets; Jürgen Floege; Hermann-Josef Gröne; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 10.121

Review 7.  Role of the glucocorticoid receptor in glomerular disease.

Authors:  Julie E Goodwin
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-05

8.  Amino acid transporter LAT3 is required for podocyte development and function.

Authors:  Yuji Sekine; Yukino Nishibori; Yoshihiro Akimoto; Akihiko Kudo; Noriko Ito; Daisuke Fukuhara; Ryota Kurayama; Eiji Higashihara; Ellappan Babu; Yoshikatsu Kanai; Katsuhiko Asanuma; Michio Nagata; Arindam Majumdar; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

9.  NPHS3: new clues for understanding idiopathic nephrotic syndrome.

Authors:  Bernward G Hinkes
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 10.  The podocyte as a direct target for treatment of glomerular disease?

Authors:  Sandeep K Mallipattu; John C He
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.